BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16264797)

  • 1. Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.
    Arya M; Chao D; Patel HR
    Nat Clin Pract Oncol; 2004 Nov; 1(1):32-8. PubMed ID: 16264797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens.
    Tykodi SS; Warren EH; Thompson JA; Riddell SR; Childs RW; Otterud BE; Leppert MF; Storb R; Sandmaier BM
    Clin Cancer Res; 2004 Dec; 10(23):7799-811. PubMed ID: 15585611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
    Childs R; Chernoff A; Contentin N; Bahceci E; Schrump D; Leitman S; Read EJ; Tisdale J; Dunbar C; Linehan WM; Young NS; Barrett AJ
    N Engl J Med; 2000 Sep; 343(11):750-8. PubMed ID: 10984562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
    Takahashi Y; Childs RW
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6353S-9S. PubMed ID: 15448030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma.
    Roigas J; Johannsen M; Ringsdorf M; Massenkeil G
    Expert Rev Anticancer Ther; 2006 Oct; 6(10):1449-58. PubMed ID: 17069529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.
    Childs RW
    Crit Rev Immunol; 2001; 21(1-3):191-203. PubMed ID: 11642604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors.
    Demirer T; Barkholt L; Blaise D; Pedrazzoli P; Aglietta M; Carella AM; Bay JO; Arpaci F; Rosti G; Gurman G; Niederwieser D; Bregni M;
    Nat Clin Pract Oncol; 2008 May; 5(5):256-67. PubMed ID: 18398414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single center prospective study.
    Ishiyama K; Takami A; Suzuki S; Konaka H; Namiki M; Ooi A; Nakao S
    Jpn J Clin Oncol; 2009 Dec; 39(12):807-12. PubMed ID: 19770130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic MHC gene transfer enhances antitumor activity of allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease.
    Ohashi M; Kobayashi A; Hara H; Miura Y; Yoshida K; Kushida M; Ikarashi Y; Mandai M; Kitajima M; Yoshida T; Aoki K
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2208-15. PubMed ID: 16609036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.
    Harlin H; Artz AS; Mahowald M; Rini BI; Zimmerman T; Vogelzang NJ; Gajewski TF
    Bone Marrow Transplant; 2004 Mar; 33(5):491-7. PubMed ID: 14716341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic hematopoietic stem cell transplantation for solid tumors in the United States: a review].
    Cheng YC; Ueno NT
    Nihon Rinsho; 2003 Sep; 61(9):1619-34. PubMed ID: 14515734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.
    Eto M; Kamiryo Y; Takeuchi A; Harano M; Tatsugami K; Harada M; Kiyoshima K; Hamaguchi M; Teshima T; Tsuneyoshi M; Yoshikai Y; Naito S
    Clin Cancer Res; 2008 May; 14(9):2833-40. PubMed ID: 18451251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmyeloablative transplantation for solid tumors: a new frontier for allogeneic immunotherapy.
    Espinoza-Delgado I; Childs RW
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):865-75. PubMed ID: 15485320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cancer treatment with low levels of mixed chimerism induced by nonmyeloablative regimen using cyclophosphamide in mice.
    Harano M; Eto M; Iwai T; Tatsugami K; Kiyoshima K; Kamiryo Y; Tsuneyoshi M; Yoshikai Y; Naito S
    Cancer Res; 2005 Nov; 65(21):10032-40. PubMed ID: 16267029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
    Rini BI; Halabi S; Barrier R; Margolin KA; Avigan D; Logan T; Stadler WM; McCarthy PL; Linker CA; Small EJ; ; ;
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):778-85. PubMed ID: 16785067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
    Nelson RP; Logan TF; Abonour R
    Bone Marrow Transplant; 2002 Dec; 30(12):805-12. PubMed ID: 12476272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hemopoietic stem cell transplantation in solid tumors.
    Carnevale-Schianca F; Ricchiardi A; Capaldi A; Bucci AR; Grignani G; Rota-Scalabrini D; Fizzotti M; Aliberti S; Aglietta M
    Transplant Proc; 2005; 37(6):2664-6. PubMed ID: 16182778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation for renal cell carcinoma.
    Bregni M; Herr W; Blaise D;
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):901-11. PubMed ID: 21707287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.